Literature DB >> 25307191

Comments on Motamedi G, Meador K. Epilepsy and cognition. Epilepsy & behavior 2003;4:S25-S28.

Robyn M Busch1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25307191      PMCID: PMC4391193          DOI: 10.1016/j.yebeh.2014.08.021

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


× No keyword cloud information.
  38 in total

1.  Determining reliable cognitive change after epilepsy surgery: development of reliable change indices and standardized regression-based change norms for the WMS-III and WAIS-III.

Authors:  Roy Martin; Stephen Sawrie; Frank Gilliam; Melissa Mackey; Edward Faught; Robert Knowlton; Ruben Kuzniekcy
Journal:  Epilepsia       Date:  2002-12       Impact factor: 5.864

2.  The role of the Wada test in the surgical treatment of temporal lobe epilepsy: an international survey.

Authors:  Sallie Baxendale; Pamela J Thompson; John S Duncan
Journal:  Epilepsia       Date:  2008-04       Impact factor: 5.864

Review 3.  An evidence-based checklist to assess neuropsychological outcomes of epilepsy surgery: how good is the evidence?

Authors:  M Hrabok; J Dykeman; E M S Sherman; S Wiebe
Journal:  Epilepsy Behav       Date:  2013-10-11       Impact factor: 2.937

4.  Empirical methods for assessing meaningful neuropsychological change following epilepsy surgery.

Authors:  S M Sawrie; G J Chelune; R I Naugle; H O Lüders
Journal:  J Int Neuropsychol Soc       Date:  1996-11       Impact factor: 2.892

5.  Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age.

Authors:  Kimford J Meador; Gus A Baker; Nancy Browning; Morris J Cohen; Jill Clayton-Smith; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  Brain       Date:  2011-01-11       Impact factor: 13.501

Review 6.  Cognitive and neurodevelopmental effects of antiepileptic drugs.

Authors:  Rebecca L Bromley; Beth A Leeman; Gus A Baker; Kimford J Meador
Journal:  Epilepsy Behav       Date:  2011-06-17       Impact factor: 2.937

7.  Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years.

Authors:  Morris J Cohen; Kimford J Meador; Nancy Browning; Gus A Baker; Jill Clayton-Smith; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  Epilepsy Behav       Date:  2011-07-23       Impact factor: 2.937

Review 8.  Sodium channels and the neurobiology of epilepsy.

Authors:  Megan Oliva; Samuel F Berkovic; Steven Petrou
Journal:  Epilepsia       Date:  2012-08-20       Impact factor: 5.864

9.  Not only a matter of epilepsy: early problems of cognition and behavior in children with "epilepsy only"--a prospective, longitudinal, controlled study starting at diagnosis.

Authors:  Kim J Oostrom; Anneke Smeets-Schouten; Cas L J J Kruitwagen; A C Boudewyn Peters; Aagje Jennekens-Schinkel
Journal:  Pediatrics       Date:  2003-12       Impact factor: 7.124

10.  Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.

Authors:  Kimford J Meador; Gus A Baker; Nancy Browning; Morris J Cohen; Rebecca L Bromley; Jill Clayton-Smith; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  Lancet Neurol       Date:  2013-01-23       Impact factor: 44.182

View more
  7 in total

1.  Improving cognitive task in kindled rats by using low frequency stimulation during epileptogenesis.

Authors:  Zohreh Ghotbeddin; Ahmad Ali Moazedi; Ali Yadollahpour; Faezeh Rendi; Mostafa Jalilifar
Journal:  Metab Brain Dis       Date:  2018-06-29       Impact factor: 3.584

2.  Weight of epilepsy in brain tumor patients.

Authors:  Marta Maschio; Francesca Sperati; Loredana Dinapoli; Antonello Vidiri; Alessandra Fabi; Andrea Pace; Alfredo Pompili; Carmine Maria Carapella; Tonino Cantelmi
Journal:  J Neurooncol       Date:  2014-05-01       Impact factor: 4.130

3.  Diagnosis of epilepsy from electroencephalography signals using multilayer perceptron and Elman Artificial Neural Networks and Wavelet Transform.

Authors:  Hakan Işik; Esma Sezer
Journal:  J Med Syst       Date:  2010-02-23       Impact factor: 4.460

Review 4.  Review of topiramate for the treatment of epilepsy in elderly patients.

Authors:  B R Sommer; H H Fenn
Journal:  Clin Interv Aging       Date:  2010-04-26       Impact factor: 4.458

Review 5.  Epilepsy, cognition and behavior.

Authors:  Sheffali Gulati; Sangeetha Yoganathan; Biswaroop Chakrabarty
Journal:  Indian J Pediatr       Date:  2014-07-31       Impact factor: 1.967

6.  Garcinol Upregulates GABAA and GAD65 Expression, Modulates BDNF-TrkB Pathway to Reduce Seizures in Pentylenetetrazole (PTZ)-Induced Epilepsy.

Authors:  Fang Hao; Li-Hua Jia; Xiao-Wan Li; Ying-Rui Zhang; Xue-Wu Liu
Journal:  Med Sci Monit       Date:  2016-11-17

7.  NRSF and BDNF polymorphisms as biomarkers of cognitive dysfunction in adults with newly diagnosed epilepsy.

Authors:  Alix Warburton; Fabio Miyajima; Kanvel Shazadi; Joanne Crossley; Michael R Johnson; Anthony G Marson; Gus A Baker; John P Quinn; Graeme J Sills
Journal:  Epilepsy Behav       Date:  2015-12-17       Impact factor: 2.937

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.